Fool.com
Growing the love for investing
Results 31 - 40 of 593 : Previous 1 2 3 4 5 6 7 8 9 Next
A Wonder Drug With Not-So-Wonderful Side Effects
Wonder drug or not, mipomersen's sales will be limited by side effects.
3 Stocks on Buffett's Wish List?
Does the Oracle of Omaha want these stocks?
Destroy Your Debt Before You Retire
Looming loan payments don't make for a happy retirement.
4-Star Stocks Poised to Pop: Myriad Genetics
CAPS investors think great returns are in this company's DNA.
FDA wants more data from Pfizer's partner, Protalix.
A stock screen looking for stocks that will hold up in a soft market.
Shaking Up the Biotech Industry
A judge will decide if genes are patentable or not.
Foolish Forecast: First Look at Pfizer Plus
Views you can use for tomorrow's news.
Now That's Some Expensive Risk Mitigation
Boston Scientific avoids a trial -- at a cost.
The Biggest Development-Stage Drugmaker, Ever
OK, so it has drugs on the market, but it certainly trades like one.
Legal Information © 1995 - 2010 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK